Effect of artemisinins and amino alcohol partner antimalarials on mammalian sarcoendoplasmic reticulum calcium adenosine triphosphatase activity

Basic and Clinical Pharmacology and Toxicology

Volumn 103, Issue 3, 2008, Pages 209-213

  Toovey, Stephen ^a,b   Bustamante, Leyla Y ^c   Uhlemann, Anne Catrin ^d   East, J Malcolm ^e   Krishna, Sanjeev ^c  

^a Royal Free and University College Medical School ^*  (Switzerland)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOALCOHOL; ANTIMALARIAL AGENT; ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ; BENFLUMETOL; DIHYDROARTEMISININ; MEFLOQUINE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; THAPSIGARGIN;

ANIMAL EXPERIMENT; ARTICLE; DRUG ACTIVITY; DRUG MECHANISM; DRUG SCREENING; ENZYME ACTIVITY; ENZYME INHIBITION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANIMALS; ANTIMALARIALS; ARTEMISININS; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOLAMINES; FLUORENES; ISOENZYMES; MEFLOQUINE; RABBITS; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; STEREOISOMERISM;

MAMMALIA; ORYCTOLAGUS CUNICULUS;

EID: 49749127236     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2008.00256.x     Document Type: Article

References (35)

1. Woodrow CJ, Haynes RK, Krishna S. Artemisinins. Postgrad Med J 2005 81 : 71 8.
2. World Health Organization. Guidelines for the Treatment of Malaria. World Health Organization, Geneva, Switzerland 2006.
3. Eckstein-Ludwig U, Webb RJ, Van Goethem ID, East JM, Lee G, Kimura M et al. Artemisinins target the SERCA of Plasmodium falciparum. Nature 2003 424 : 957 61.
4. Meshnick SR. Artemisinin and heme. Antimicrob Agents Chemother 2003 47 : 2712 3.
5. Krishna S, Woodrow CJ, Staines HM, Haynes RK, Mercereau-Puijalon O. Re-evaluation of how artemisinins work in light of emerging evidence of in vitro resistance. Trends Mol Med 2006 12 : 200 5.
6. Frank KF, Bolck B, Brixius K, Kranias EG, Schwinger RH. Modulation of SERCA: implications for the failing human heart. Basic Res Cardiol 2002 97 (Suppl 1 I72 8.
7. 2+-ATPase in a mouse model of Sandhoff disease and prevention by treatment with N-butyldeoxynojirimycin. J Biol Chem 2003 278 : 29496 501.
8. Muller EJ, Caldelari R, Kolly C, Williamson L, Baumann D, Richard G et al. Consequences of depleted SERCA2-gated calcium stores in the skin. J Invest Dermatol 2006 126 : 721 31.
9. Meier CR, Wilcock K, Jick SS. The risk of severe depression, psychosis or panic attacks with prophylactic antimalarials. Drug Saf 2004 27 : 203 13.
10. van Riemsdijk MM, Ditters JM, Sturkenboom MC, Tulen JH, Ligthelm RJ, Overbosch D et al. Neuropsychiatric events during prophylactic use of mefloquine before travelling. Eur J Clin Pharmacol 2002 58 : 441 5.
11. Weinke T, Trautmann M, Held T, Weber G, Eichenlaub D, Fleischer K et al. Neuropsychiatric side effects after the use of mefloquine. Am J Trop Med Hyg 1991 45 : 86 91.
12. Dow GS, Hudson TH, Vahey M, Koenig ML. The acute neurotoxicity of mefloquine may be mediated through a disruption of calcium homeostasis and ER function in vitro. Malar J 2003 2 : 14.
13. Jung TT, Rhee CK, Lee CS, Park YS, Choi DC. Ototoxicity of salicylate, nonsteroidal antiinflammatory drugs, and quinine. Otolaryngol Clin North Am 1993 26 : 791 810.
14. Karlsson KK, Berninger E, Alvan G. The effect of quinine on psychoacoustic tuning curves, stapedius reflexes and evoked otoacoustic emissions in healthy volunteers. Scand Audiol 1991 20 : 83 90.
15. Puel JL, Bobbin RP, Fallon M. Salicylate, mefenamate, meclofenamate, and quinine on cochlear potentials. Otolaryngol Head Neck Surg 1990 102 : 66 73.
16. 2+-ATPase (PfATP4) belonging to a subclass unique to apicomplexan organisms. J Biol Chem 2001 276 : 10782 7.
17. Woodrow CJ, Penny JI, Krishna S. Intraerythrocytic Plasmodium falciparum expresses a high affinity facilitative hexose transporter. J Biol Chem 1999 274 : 7272 7.
18. 2+ buffers. Methods Cell Biol 1994 40 : 3 29.
19. Davis TME, Phuong HL, Ilett KF, Hung NC, Batty KT, Phuong VDB et al. Pharmacokinetics and pharmacodynamics of intravenous artesunate in severe falciparum malaria. Antimicrob Agents Chemother 2001 45 : 181 6.
20. Toovey S. Are currently deployed artemisinins neurotoxic? Toxicol Lett 2006 166 : 95 104.
21. Clark RL, White TEK, Clode SA, Gaunt I, Winstanley P, Ward SA. Developmental toxicity of artesunate and an artesunate combination in the rat and rabbit. Birth Defects Res Part B Dev Reprod Toxicol 2004 71 : 380 94.
22. Longo M, Zanoncelli S, Manera D, Brughera M, Colombo P, Lansen J et al. Effects of the antimalarial drug dihydroartemisinin (DHA) on rat embryos in vitro. Reprod Toxicol 2006 21 : 83 93.
23. Mesembe OE, Ivang AE, Udo-Affah G, Igiri AO, Fischer VA, Akpaso M et al. A morphometric study of the teratogenic effect of artesunate on the central nervous system of the Wistar rat foetus. Niger J Physiol Sci 2004 19 : 92 7.
24. 2+ uptake by crude microsomes of rabbit skeletal muscle. Arch Int Pharmacodyn Ther 1995 329 : 255 71.
25. 2+ uptake and release by dog brain microsomes. Arch Int Pharmacodyn Ther 1996 331 : 221 31.
26. Nguyen HN, Wang C, Perry DC. Depletion of intracellular calcium stores is toxic to SH-SY5Y neuronal cells. Brain Res 2002 924 : 159 66.
27. Dow GS, Caridha D, Goldberg M, Wolf L, Koenig ML, Yourick DL et al. Transcriptional profiling of mefloquine-induced disruption of calcium homeostasis in neurons in vitro. Genomics 2005 86 : 539 50.
28. Krishna S, Planche T, Agbenyega T, Woodrow C, Agranoff D, Bedu-Addo G et al. Bioavailability and preliminary clinical efficacy of intrarectal artesunate in Ghanaian children with moderate malaria. Antimicrob Agents Chemother 2001 45 : 509 16.
29. Karbwang J, Na-Bangchang K, Tin T, Sukontason K, Rimchala W, Harinasuta T. Pharmacokinetics of intramuscular artemether in patients with severe falciparum malaria with or without acute renal failure. Br J Clin Pharmacol 1998 45 : 597 600.
30. Dao NV, Quoc NP, Ngoa ND, Thuy LT, The ND, Dai B et al. Fatty food does not alter blood mefloquine concentrations in the treatment of falciparum malaria. Trans R Soc Trop Med Hyg 2005 99 : 927 31.
31. Ezzet F, van Vugt M, Nosten F, Looareesuwan S, White NJ. Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria. Antimicrob Agents Chemother 2000 44 : 697 704.
32. Ezzet F, Mull R, Karbwang J. Population pharmacokinetics and therapeutic response of CGP 56697 (artemether + benflumetol) in malaria patients. Br J Clin Pharmacol 1998 46 : 553 61.
33. Stohrer JM, Dittrich S, Thongpaseuth V, Vanisaveth V, Phetsouvanh R, Phompida S et al. Therapeutic efficacy of artemether-lumefantrine and artesunate-mefloquine for treatment of uncomplicated Plasmodium falciparum malaria in Luang Namtha Province, Lao People's Democratic Republic. Trop Med Int Health 2004 9 : 1175 83.
34. Noedl H, Allmendinger T, Prajakwong S, Wernsdorfer G, Wernsdorfer WH. Desbutyl-benflumetol, a novel antimalarial compound: in vitro activity in fresh isolates of Plasmodium falciparum from Thailand. Antimicrob Agents Chemother 2001 45 : 2106 9.
35. 2+-ATPase of sarcoplasmic reticulum from paired inhibitor studies. Biochemistry 2002 41 : 2869 75.